Injection drug use limits benefits of surgery for treatment of heart lining infection
Tuesday, September 1, 2015 - 10:00
in Health & Medicine
Injection drug users who undergo surgery for infective endocarditis (IE) have a significantly higher risk of reoperation or death between 3 and 6 months after surgery compared to patients who develop endocarditis who are not IV drug abusers.